5,514
Views
114
CrossRef citations to date
0
Altmetric
Original Articles

Delivery of curcumin by a pH-responsive chitosan mesoporous silica nanoparticles for cancer treatment

, , ORCID Icon, &
Pages 75-81 | Received 27 Nov 2016, Accepted 31 Jan 2017, Published online: 23 Feb 2017

References

  • Adahoun MA, Al-Akhras MAH, Jaafar MS, Bououdina M. 2016. Enhanced anti-cancer and antimicrobial activities of curcumin nanoparticles. Artif Cell Nanomed Biotechnol. 45:98–107.
  • Al-Rasheed NM, Fadda LM, Ali HM, Abdel Baky NA, El-Orabi NF, Al-Rasheed NM, Yacoub HI. 2016. New mechanism in the modulation of carbon tetrachloride hepatotoxicity in rats using different natural antioxidants. Toxicol Mech Methods. 26:243–250.
  • Basnet P, Hussain H, Tho I, Skalko-Basnet N. 2012. Liposomal delivery system enhances anti‐inflammatory properties of curcumin. J Pharm Sci. 101:598–609.
  • Bollu VS, Barui AK, Mondal SK, Prashar S, Fajardo M, Briones D, et al. 2016. Curcumin-loaded silica-based mesoporous materials: Synthesis, characterization and cytotoxic properties against cancer cells. Mater Sci Eng C Mater Biol Appl. 63:393–410.
  • Caka M, Türkcan C, Uygun AD, Uygun M, Akgöl S, Denizli A. 2016. Controlled release of curcumin from poly (HEMA-MAPA) membrane. Artif Cells Nanomed Biotechnol. [Epub ahead of print]. http://dx.doi.org/10.3109/21691401.2016.1160913
  • Connell LS, Romer F, Suarez M, Valliant EM, Zhang Z, Lee PD, et al. 2014. Chemical characterisation and fabrication of chitosan-silica hybrid scaffolds with 3-glycidoxypropyl trimethoxysilane. J Mater Chem B. 2:668–680.
  • Cui L, Lin H, Guo W, Xiang D, Zhou D, Zhang T, Qu F. 2014. A novel pH-responsive controlled release system based on mesoporous silica coated with hydroxyapatite. J Sol-Gel Sci Technol. 72:106–113.
  • Du L, Feng X, Xiang X, Jin Y. 2016. Wound healing effect of an in situ forming hydrogel loading curcumin-phospholipid complex. Curr Drug Deliv. 13:76–82.
  • Fang L, Gou S, Liu X, Cao F, Cheng L. 2014. Design, synthesis and anti-Alzheimer properties of dimethylaminomethyl-substituted curcumin derivatives. Bioorg Med Chem Lett. 24:40–43.
  • Garg T. 2016. Current nanotechnological approaches for an effective delivery of bio-active drug molecules in the treatment of acne. Artif Cells Nanomed Biotechnol. 44:98–105.
  • Ghalandarlaki N, Alizadeh AM, Ashkani-Esfahani S. 2014. Nanotechnology-applied curcumin for different diseases therapy. BioMed Res Int. 2014,
  • Gou M, Men K, Shi H, Xiang M, Zhang J, Song J, et al. 2011. Curcumin-loaded biodegradable polymeric micelles for colon cancer therapy in vitro and in vivo. Nanoscale. 3:1558–1567.
  • Heikkilä T, Salonen J, Tuura J, Kumar N, Salmi T, Murzin DY, et al. 2007. Mesoporous silica material TUD-1 as a drug delivery system. Int J Pharm. 331:133–138.
  • Hu X, Wang Y, Peng B. 2014. Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release. Chem Asian J. 9:319–327.
  • Jambhrunkar S, Karmakar S, Popat A, Yu M, Yu C. 2014. Mesoporous silica nanoparticles enhance the cytotoxicity of curcumin. RSC Adv. 4:709–712.
  • Jin R, Xia Y, Chen Q, Li W, Chen D, Ye H, et al. 2016. Da0324, an inhibitor of nuclear factor-kappaB activation, demonstrates selective antitumor activity on human gastric cancer cells. Drug Des Dev Ther. 10:979–995.
  • Kilicay E, Karahaliloglu Z, Hazer B, Tekin IÖ, Denkbas EB. 2016. Concanavaline A conjugated bacterial polyester-based PHBHHx nanoparticles loaded with curcumin for breast cancer therapy. J Microencapsul. 33:1–12.
  • Liu W, Yuan J, Zhu H, Zhang X, Li L, Liao X, et al. 2016. Curcumin reduces brain-infiltrating T lymphocytes after intracerebral hemorrhage in mice. Neurosci Lett. 620:74–82.
  • Mamaeva V, Sahlgren C, Lindén M. 2013. Mesoporous silica nanoparticles in medicine—Recent advances. Adv Drug Deliv Rev. 65:689–702.
  • Mirakabad FST, Akbarzadeh A, Milani M, Zarghami N, Taheri-Anganeh M, Zeighamian V, et al. 2016. A comparison between the cytotoxic effects of pure curcumin and curcumin-loaded PLGA-PEG nanoparticles on the MCF-7 human breast cancer cell line. Artif Cells Nanomed Biotechnol. 44:423–430.
  • Nasab AN, Kumleh HH, Kazemzad M, Ghavipanjeh F. 2014. Application of spherical mesoporous silica MCM-41 for adsorption of dibenzothiophene (a sulfur containing compound) from model oil. Iran J Chem Chem Eng (IJCCE). 33:37–42.
  • Park W, Amin AR, Chen ZG, Shin DM. 2013. New perspectives of curcumin in cancer prevention. Cancer Prev Res. 6:387–400.
  • Paulino N, Paulino AS, Diniz SN, de Mendonça S, Gonçalves ID, Faião Flores F, et al. 2016. Evaluation of the anti-inflammatory action of curcumin analog (DM1): Effect on iNOS and COX-2 gene expression and autophagy pathways. Bioorg Med Chem. 24:1927–1935.
  • Popat A, Liu J, Lu GQM, Qiao SZ. 2012. A pH-responsive drug delivery system based on chitosan coated mesoporous silica nanoparticles. J Mater Chem. 22:11173–11178.
  • Pourjavadi A, Tehrani ZM. 2014. Mesoporous silica nanoparticles (MCM-41) coated PEGylated chitosan as a pH-responsive nanocarrier for triggered release of erythromycin. Int J Polymeric Mater Polym Biomater. 63:692–697.
  • Rampino A, Borgogna M, Blasi P, Bellich B, Cesàro A. 2013. Chitosan nanoparticles: preparation, size evolution and stability. Int J Pharm. 455:219–228.
  • Singh N, Karambelkar A, Gu L, Lin K, Miller JS, Chen CS, et al. 2011. Bioresponsive mesoporous silica nanoparticles for triggered drug release. J Am Chem Soc. 133:19582–19585.
  • Sun D, Zhuang X, Xiang X, Liu Y, Zhang S, Liu C, et al. 2010. A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. Mol Ther. 18:1606–1614.
  • Tao Z, Toms B, Goodisman J, Asefa T. 2010. Mesoporous silica microparticles enhance the cytotoxicity of anticancer platinum drugs. ACS Nano. 4:789–794.
  • Taverna S, Fontana S, Monteleone F, Pucci M, Saieva L, Caro VD, et al. 2016. Curcumin modulates chronic myelogenous leukemia exosomes composition and affects angiogenic phenotype, via exosomal miR-21.
  • Teiten MH, Dicato M, Diederich M. 2014. Hybrid curcumin compounds: a new strategy for cancer treatment. Molecules. 19:20839–20863.
  • Vyskočilová E, Luštická I, Paterová I, Machová L, Cervený L. 2014. Modified MCM-41 as a drug delivery system for acetylsalicylic acid. Solid State Sci. 38:85–89.
  • Woraphatphadung T, Sajomsang W, Gonil P, Treetong A, Akkaramongkolporn P. 2016. pH-Responsive polymeric micelles based on amphiphilic chitosan derivatives: Effect of hydrophobic cores on oral meloxicam delivery. Int J Pharm. 497:150–160.
  • Wu GQ, Chai KQ, Zhu XM, Jiang H, Wang X, Xue Q, et al. 2016. Anti-cancer effects of curcumin on lung cancer through the inhibition of EZH2 and NOTCH1. Oncotarget. 7:26535–26550.
  • Xu W, Riikonen J, Lehto VP. 2013. Mesoporous systems for poorly soluble drugs. Int J Pharm. 453:181–197.
  • Yang P, Gai S, Lin J. 2012. Functionalized mesoporous silica materials for controlled drug delivery. Chem Soc Rev. 41:3679–3698.
  • Yun DG, Lee DG. 2016. Antibacterial activity of curcumin via apoptosis-like response in Escherichia coli. Appl Microbiol Biotechnol. 100:5505–5514.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.